Financials

  • Market Capitalization 260.93 M
  • Employee 44
  • Founded 2015
  • CEO N/A
  • Website www.surrozen.com
  • Headquarter Delaware, United States
  • FIGI BBG00XY94S95
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.66
ratio cours/chiffre d'affaires
0.04

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3408
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
3.71 USD-1.33%-4.13%-22.55%+119.53%265.90 M USD
3410
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.63 USD+1.98%-8.86%+19.33%+53.82%263.95 M USD
3426
IVVD
Invivyd, Inc. - Common Stock
0.88 USD-7.37%-4.35%+57.14%-13.73%259.39 M USD
3431
MGNX
MacroGenics, Inc. - Common Stock
4.04 USD+1.25%-2.88%+8.60%+132.18%257.35 M USD

Nouvelles